Recent Updates
Recently added Catalysts
BAX Positive Sentiment

Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

Key Takeaway: Baxter International Inc. announced the upcoming U.S. launch of the Dynamo Series stretcher at the 2026 J.P. Morgan Healthcare Conference. This innovative stretcher is designed to reduce the physical and cognitive burdens on care teams while enhancing patient safety and comfort. It will be available for order in the U.S. and is expected to launch in the first half of 2026.
Price reaction · baseline $20.15 (2026-01-12 close) · hit pre-market · clean, no other BAX news in the window
day 0 close · peak
-2.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Dynamo Series aims to enhance patient care and safety.
  • Designed to alleviate burdens on healthcare teams.
  • Expected to improve patient experience in various settings.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+18%
120-day peak, hindsight
Typical move
1.9%
average across 12 past catalysts
Lead asset
Dianeal
Phase 3 · End Stage Renal Disease (ESRD)

Full Press Release Details

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovator in smart beds for med-surg and the intensive care unit, announced at the 2026 J.P. Morgan Healthcare Conference the upcoming U.S. launch of theDynamo Seriesstretcher. TheDynamo Seriesis a stretcher designed to help alleviate the physical and cognitive burden on care teams1and make it easier for them to focus on patient care, while improving the patient’s experience. Intended for use in emergency departments, perioperative environments and patient transport services, theDynamo Seriesis the latest innovation in Baxter’s leading portfolio of smart beds, surfaces and connected care solutions.
“At Baxter, we are committed to driving focused innovation that empowers clinicians to deliver exceptional patient care in high-pressure environments,” said James Teaff, president of Care & Connectivity Solutions at Baxter. “The stretcher is a vital bridge between care teams and patients. We designed theDynamo Seriesto strengthen these connections by addressing some of the toughest challenges care teams face,2including reducing the need for patient transfers and simplifying patient positioning across a range of procedures.”3

TheDynamo Seriesis intended to help enhance the care team experience, prevent patient falls and improve patient safety and comfort.

TheDynamo Seriesis now available for order in the U.S. and is expected to be available during the first half of 2026.

About Baxter

At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician’s office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched portfolio of connected solutions, medical devices, and advanced injectable technologies. Approximately, 38,000 Baxter team members live our enduring mission: to save and sustain lives. Together, we are redefining how care is delivered to make a greater impact today, tomorrow, and beyond. To learn more, visitwww.baxter.comand follow us onX,LinkedInandFacebook.
For safe and proper use of this device, please refer to the full Instructions for Use.
This release includes forward-looking statements concerning potential benefits associated with theDynamo Seriesand the anticipated timing of its release. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance for new and existing products; product development risks; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of natural disasters, public health crises and epidemics/pandemics, regulatory actions or otherwise); satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter's most recent filing on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.

Baxter,Dynamo Series, VoalteandSafeView+are trademarks of Baxter International Inc. or its subsidiaries.

1Data on file at Baxter International Inc. December 9, 2025.2Data on file at Baxter International Inc. External Market Research Report. December 8, 2025.3Dynamo Series Stretcher IFU. 220146 rev 1. December 19, 20254Agency for Healthcare Research and Quality: Preventing falls in hospitals. 20245Carle Health. Utilization of Fall Prevention Technologies in Hospital Beds. Posted Presented September 2025.6Data on file at Baxter International Inc. December 9, 2025.7Wiggermann et al., (2017). What Bed Size Does a Patient Need? The Relationship Between Body Mass Index and Space Required to Turn in Bed. Nursing Research, 66(6), 483-489.

Frequently Asked Questions

What is the Dynamo Series stretcher?

The Dynamo Series stretcher is an innovative device designed to enhance patient care and safety.

When will the Dynamo Series be available?

The stretcher is expected to be available for order in the U.S. in the first half of 2026.

How does the Dynamo Series help care teams?

It alleviates physical and cognitive burdens, allowing teams to focus more on patient care.

What environments is the Dynamo Series intended for?

It is designed for use in emergency departments, perioperative settings, and patient transport.

Last updated: Jan 13, 2026